President Joe Biden and Vice President Kamala Harris responded to the Supreme Court’s ruling on mifepristone.
The White House released statements from both Biden and Harris Friday evening responding to the Supreme Court’s ruling allowing mifepristone for now. The Court ruled on Friday that the FDA’s approval of the abortifacient drug, used in nearly half of abortions nationwide, could remain in place while the Fifth Circuit Court of Appeals hears a lawsuit.
“Today, the Supreme Court granted the Department of Justice’s emergency stay application in Alliance for Hippocratic Medicine v. FDA, preventing a lower court decision from going into effect that would have undermined FDA’s medical judgment and put women’s health at risk,” Biden’s statement read. “As a result of the Supreme Court’s stay, mifepristone remains available and approved for safe and effective use while we continue this fight in the courts. I continue to stand by FDA’s evidence-based approval of mifepristone, and my Administration will continue to defend FDA’s independent, expert authority to review, approve, and regulate a wide range of prescription drugs.”
“The stakes could not be higher for women across America,” Biden added. “I will continue to fight politically-driven attacks on women’s health. But let’s be clear – the American people must continue to use their vote as their voice, and elect a Congress who will pass a law restoring the protections of Roe v Wade.”
“We welcome the Supreme Court’s decision to grant a stay in Alliance for Hippocratic Medicine v. FDA, and our fight to defend reproductive freedom continues,” Harris added in her statement. “The Court’s announcement preserves access to mifepristone—a safe and effective medication that was approved by the FDA more than two decades ago.”
“Our Administration will not waver in our commitment to preserving access to essential medication and defending the FDA’s ability to approve safe and effective drugs,” she continued. “Americans need to look no further than their medicine cabinet to see how many FDA-approved medications are at risk if lower court decisions disregarding the FDA’s scientific judgment are allowed to stand. The President and I will continue to fight to protect a woman’s freedom to make decisions about her own body and access to reproductive health care, including medication abortion. No one should stand between a woman and her doctor.”
On Friday, the nation’s highest court blocked a ruling from a federal judge in Texas that placed restrictions on the FDA’s approval of the drug. The Supreme Court ruled to allow the approval of the drug while a lawsuit proceeds in federal court, granting requests from the Biden administration and the manufacturer.
CLICK HERE TO GET THE DAILY WIRE APP
“The applications for stays presented to JUSTICE ALITO and by him referred to the Court are granted,” the Court wrote in its decision. “The April 7, 2023 order of the United States District Court for the Northern District of Texas, case No. 2:22–cv–223, is stayed pending disposition of the appeal in the United States Court of Appeals for the Fifth Circuit and disposition of a petition for a writ of certiorari, if such a writ is timely sought. Should certiorari be denied, this stay shall terminate automatically. In the event certiorari is granted, the stay shall terminate upon the sending down of the judgment of this Court.”